GPNMB and ovarian carcinoma: The dual-luciferase reporter assay further confirmed that GPNMB was indeed the target of miR-532-3p.When GPNMB was interfered with, it led to the inhibition of several key aspects in ovarian cancer cells, including their proliferation, migration, invasion, glucose consumption, and lactate production.